Old Mission Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Old Mission Capital’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,200	Closed	-$236K	–	913
2024 Q3	$236K	Sell	9,200 -9,500	-51%	-$242K	﹤0.01%	1052
2024 Q2	$439K	Buy	+18,700	New	+$472K	0.01%	786
2022 Q2	–	Sell	-19,981	Closed	-$918K	–	1461
2022 Q1	$918K	Buy	+19,981	New	+$953K	0.03%	510

Other funds holding ARKG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Old Mission Capital's ARKG Position: Q4 2024 in Review

Old Mission Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 9,200 shares — an estimated $236K sold.

Old Mission Capital first reported a position in ARKG in Q1 2022 and held it in 3 quarters. The position peaked at $918K in Q1 2022. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

Old Mission Capital reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
Old Mission Capital sold 9,200 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $236K.
Old Mission Capital first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 3 quarters.
Old Mission Capital's ARK Genomic Revolution ETF position peaked at $918K in Q1 2022.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Old Mission Capital's 13F filing for Q4 2024, filed 12 Feb 2025.